Unknown PHASE4 INTERVENTIONAL 2-arm NCT01819441

Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients (APPROVE)

Azelnidipine vs Perindopril and Stratification of Blood Pressure Control Against Progress of Cerebral Small Vessel Diseases in Poststroke Patients (APPROVE):Multi-center Randomized Controlled Clinical Trial

Sponsor: Yining Huang

Conditions Cerebral Small Vessel Diseases

Interventions Azelnidipine Perindopril hydrochlorothiazide

Updated 6 times since 2017 Last updated: Oct 22, 2015 Started: May 31, 2012 Primary completion: Dec 31, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Cerebral Small Vessel Diseases, this trial is ongoing. The trial is conducted by Yining Huang and has accumulated 6 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Oct 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Oct 2017 [monthly]

Recruiting PHASE4

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yining Huang

Data source: Peking University First Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China